{"count": 1, "results": [{"_id": "15529521", "pmid": 15529521, "title": "Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.", "journal": "Int J Clin Pract", "authors": ["Bailey CJ", "Day C"], "date": "2004-09-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2004.00318.x", "meta_date_publication": "2004 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "867-76", "score": 50078.207, "text_hl": "@<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@: combined @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ treatment for @<m>DISEASE_Insulin_Resistance</m> @DISEASE_MESH:D007333 @@@insulin resistance@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Bailey CJ, Day C. Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Int J Clin Pract. 2004 Sep;58(9):867-76. PMID: 15529521", "BibTeX": "@article{15529521, title={Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.}, author={Bailey CJ and Day C}, journal={Int J Clin Pract}, volume={58}, number={9}, pages={867-76}}"}}]}